Popular Trials
Reinforced Tissue Matrix
OviTex Mesh for Hernia Repair
Recruiting1 award9 criteria
Overland Park, Kansas
This trial is testing a special mesh called OviTex in patients with ventral or inguinal hernias who are having robotic surgery. The goal is to see if this mesh can lower the risk of complications and prevent the hernia from returning. OviTex is designed to provide better support for the abdominal wall.
Procedure
Local vs General Anesthesia for Inguinal Hernia Repair in Older Adults
Recruiting1 award4 criteria
Dallas, Texas
This trial aims to determine which type of anesthesia is best for hernia repair in older adults: general or local. It seeks to address unanswered questions about the effects of anesthetic technique on cognitive function and quality of life.
Popular Filters
Trials for Congenital Diaphragmatic Hernia Patients
Inotrope and Lusitrope
Milrinone for Congenital Diaphragmatic Hernia
Recruiting0 awardsPhase 2
Birmingham, Alabama
This trial is testing if milrinone, a medicine that helps the heart and lungs, can improve oxygen levels in newborns with severe lung and heart problems due to CDH. These babies often don't get better with usual treatments. The goal is to see if milrinone can safely help these babies breathe easier. Milrinone is used in up to 30% of CDH infants across the United States, but no studies have tested its effectiveness or safety in these newborns.
Procedure
FETO Surgery for Congenital Diaphragmatic Hernia
Recruiting1 award
San Francisco, California
This trial is testing a new fetal therapy for babies with severe Congenital Diaphragmatic Hernia (CDH). The goal is to improve neonatal survival rates by increasing lung growth while the baby is still in the womb.
Procedure
FETO for Congenital Diaphragmatic Hernia
Recruiting1 award
Ann Arbor, Michigan
This trial is to test the feasibility and safety of a new treatment for severe CDH. It will enroll pregnant women who meet the criteria and who live close to the hospital. There are some lifestyle considerations that the participants must be aware of.
Trials for CDH Patients
Inotrope and Lusitrope
Milrinone for Congenital Diaphragmatic Hernia
Recruiting0 awardsPhase 2
Birmingham, Alabama
This trial is testing if milrinone, a medicine that helps the heart and lungs, can improve oxygen levels in newborns with severe lung and heart problems due to CDH. These babies often don't get better with usual treatments. The goal is to see if milrinone can safely help these babies breathe easier. Milrinone is used in up to 30% of CDH infants across the United States, but no studies have tested its effectiveness or safety in these newborns.
Procedure
FETO Surgery for Congenital Diaphragmatic Hernia
Recruiting1 award
San Francisco, California
This trial is testing a new fetal therapy for babies with severe Congenital Diaphragmatic Hernia (CDH). The goal is to improve neonatal survival rates by increasing lung growth while the baby is still in the womb.
Procedure
FETO for Congenital Diaphragmatic Hernia
Recruiting1 award
Ann Arbor, Michigan
This trial is to test the feasibility and safety of a new treatment for severe CDH. It will enroll pregnant women who meet the criteria and who live close to the hospital. There are some lifestyle considerations that the participants must be aware of.
Trials With No Placebo
Biomaterial
Gore ENFORM Device for Hernia Repair
Recruiting1 award4 criteria
Sarasota, Florida
This trial is studying a special material called GORE® ENFORM Biomaterial used in hernia repair surgeries. It focuses on patients with specific types of hernias to see how well this material works in real-world conditions. The material helps by acting as a supportive patch during surgery, making the repaired area stronger. GORE® ENFORM Biomaterial is a type of synthetic material used in hernia repair surgeries, known for its effectiveness in providing quick, simple, and effective repair of tissue defects in the abdominal wall.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.